Fundz

Conmed Announces Definitive Agreement To Acquire In2Bones Global, Inc.

PUBLIC · CNMDMay 04, 2022

Acquiring Company

CONMED Corporation

Acquired Company

In2Bones Global

Tampa BayManufacturingBiotechnologyHealth CareMedicalMedical DeviceImage RecognitionManufacturingHealth Care

Description

CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately-held In2Bones Global, Inc. (In2Bones), on a cash-free, debt-free basis, for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period. The transaction is not subject to a financing condition. The transaction is subject to customary closing conditions, including receipt of U.S. regulatory approval, and is expected to close late in the second quarter or early in the third quarter of 2022.

Company Information

Company

CONMED Corporation

Location

Tampa Bay, Florida, United States

About

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Fundz sees it the moment CONMED Corporation makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Patrick
Likely contact at this company
••••••••@••••••••

See Patrick's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for CONMED Corporation's next move

Learn about Strategic plan

Frequently asked

Who acquired In2Bones Global?

In2Bones Global was acquired by CONMED Corporation, based in Tampa Bay. The deal was reported on May 4, 2022. CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. CONMED Corporation is publicly traded (CNMD) and operates in Manufacturing.

When did CONMED Corporation acquire In2Bones Global?

CONMED Corporation's acquisition of In2Bones Global was reported on May 4, 2022. CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately-held In2Bones Global, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does In2Bones Global do?

Headquartered in Memphis, Tennessee, In2Bones is a global developer manufacturer and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. It is privately held, operating in Manufacturing.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.